GLP-1R antibody | knockout validation | Santa Cruz sc-390774

This is a knockout-validated antibody summary, based on the publication "Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

GLP-1R antibody | knockout validation | Santa Cruz sc-390774 figure 1
Figure 1. GLP-1R and β-actin expression in lenti-CRISPR/Cas9 mediated GLP-1R KO microglia. From [1].
Antibody information

Mouse monoclonal IgG2a κ

Company: Santa Cruz

Antibody: GLP-1R

Catalog number: sc-390774

Summary: Mouse monoclonal antibody against amino acids 91-145 mapping within an N-terminal extracellular domain of human GLP-1R. Recommended for detection of GLP-1R of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence and ELISA.

Validation Method

Western blot

Sample

Control and GLP-1R KO mouse microglia.

Blocking agent

3% BSA for 1 h at RT.

Primary incubation

1:1,000 dilution overnight at 4 ℃.

Secondary incubation

HRP-conjugated secondary antibodies for 1 h at RT.

Detection

ECL Western Blotting Substrate (Promega Corporation, Madison, WI, USA).

References
  1. Park J, Kam T, Lee S, Park H, Oh Y, Kwon S, et al. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease. Acta Neuropathol Commun. 2021;9:78 pubmed publisher